BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38159821)

  • 1. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
    Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
    J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J
    J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics.
    Zhou F; Wang W; Xu R; Liu L; Lin T; He L; Tang L; Wang X; He Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117343. PubMed ID: 37879509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
    Liu H; Li X; Duan Y; Xie JB; Piao XL
    J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-binding domain 2 of nucleolin is important for the autophagy induction of curcumol in nasopharyngeal carcinoma cells.
    Liu G; Wang J; Han M; Li X; Zhou L; Dou T; Liu Y; HuangFu M; Guan X; Wang Y; Tang W; Liu Z; Li L; Ding H; Chen X
    Phytomedicine; 2023 Jul; 115():154833. PubMed ID: 37137203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis.
    Deng JW; Yuan S; Shi LP; Chen X; Liu J; Chen ZW; Tan KY; Yang Q; Cao WF
    J Ethnopharmacol; 2024 Apr; 323():117730. PubMed ID: 38190954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.
    Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ
    Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
    Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
    Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.
    Yang F; Qian XJ; Qin W; Deng R; Wu XQ; Qin J; Feng GK; Zhu XF
    PLoS One; 2013; 8(3):e59879. PubMed ID: 23533654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
    Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
    Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical efficacy and involvement of mTOR signaling in the mechanism of Orf virus against nasopharyngeal carcinoma cells.
    Huang Y; Gong K; Chen J; Deng H; Weng K; Wu H; Li K; Xiao B; Luo S; Hao W
    Life Sci; 2022 Feb; 291():120297. PubMed ID: 35007565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.